Flen Pharma

FlandersBio on Twitter

VIB INKS QBASE+ GROUP LICENSING AGREEMENT WITH BIOGAZELLE: http://t.co/EkimyQQSZW

posted

Social Media

Life Sciences Database

in het nederlands

FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.

Website: http://www.flenpharma.com
Email:
Phone: +32 3 825 70 63
FlandersBio Member
More address details

Business Focus

Flen Pharma develops innovative topical products for improving the quality of life of patients that suffer from infections or inflammations. Flen Pharma started its activities in wound care - including burns, venous and diabetic ulcers, bedsores, grazes and post-operative wounds - and wound-bed preparation.

Company Profile

Flen Pharma was established as a result of research performed by its CEO Philippe Sollie, a pharmacist, during the 1990s. Activities focus on the discovery and development of novel wound treatments that significantly enhance the healing process, provide improved patient comfort and offer advanced methods in the clinical setting.

Science & Technology or Services

Products currently on the market include Flamigel(R), Flamispray (R), Flaminal(R) Forte and Flaminal(R) Hydro, which are based on the moist wound healing principle and originate from patented biological antimicrobial and antiinflammatory applications. Flamirins (R), Flamiclens (R) are both isotonic, slightly acidic wound rinse solutions used in hospital and home care settings. Ongoing research at the company’s laboratories a is focused on the continuing development of products for the topical treatment of inflammation and infection.

The company's expertise is situated in following domains:

Microbiology (small scale screening towards novel antimicrobials, in both aerobic and anaerobic cultures)
Microbial biofilm studies
Cell biology: cytotoxicity studies and cytokine profiling